Biologic Tapering Study of TNF Inhibitors in Axial Spondyloarthritis
NCT05115903
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Axial Spondyloarthritis
Interventions
DRUG:
Tapered doses of TNFi
DRUG:
Standard dose of TNFi
Sponsor
University Health Network, Toronto